ResMed Inc. (RMD) Cash Flow Statement
Where RMD’s cash came from and went, FY2026
June 30, 2026 · U.S. dollars- Cash from operations
- $1.81B +3.1% vs FY2025
- Capital expenditures
- $156.3M 2.8% of revenue
- Free cash flow
- $1.65B 29.2% margin
- Returned to shareholders
- $1.05B 64% of free cash flow
- Change in cash
- $259.8M cash at year-end $1.47B
Cash from operations
$1.81B
Capital expenditures
−$156.3M
Investments (net)
−$17.3M
Acquisitions & other
−$371.6M
Dividends
−$349.7M
Share buybacks (net)
−$700.0M
Net borrowing (repayment)
−$10.0M
Shares issued
+$74.5M
Other financing
−$21.8M
Change in cash
$259.8M
Drawn to scale: where the cash came from and how it was used. Hover for values.
RMD operating cash flow, capex and free cash flow
Operating cash flowCapital expendituresFree cash flowFCF margin (right axis)
RMD cash flow trends, FY2017–FY2026
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Operating cash flow | $414.1MFY2017 | $1.81BFY2026 | +17.8%/yr | |
| Capital expenditures | $71.5MFY2017 | $156.3MFY2026 | +9.1%/yr | |
| Free cash flow | $342.6MFY2017 | $1.65BFY2026 | +19.1%/yr | |
| Free cash flow margin | 16.6%FY2017 | 29.2%FY2026 | +12.6 pts | |
| Operating cash flow / net income | 1.21FY2017 | 1.19FY2026 | −0.02 | |
| Stock-based compensation | $45.9MFY2017 | $104.3MFY2026 | +9.5%/yr | |
| Dividends paid | $186.3MFY2017 | $349.7MFY2026 | +7.2%/yr | |
| Share buybacks (net) | $102.1MFY2017 | $700.0MFY2026 | +23.9%/yr | |
| Capex / revenue | 3.5%FY2017 | 2.8%FY2026 | −0.7 pts |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
RMD cash flow by activity
OperatingInvestingFinancingChange in cash
RMD net income vs operating cash flow
Net incomeOperating cash flow
Operating cash flow above net income usually means earnings are backed by cash (depreciation and stock-based pay are non-cash expenses).
RMD cash flow statement
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating activities | ||||||||||
| Net income | $1.52B | $1.40B | $1.02B | $897.6M | $779.4M | $474.5M | $621.7M | $404.6M | $315.6M | $342.3M |
| Depreciation & amortization | $244.2M | $235.8M | $216.2M | $197.6M | $193.8M | $191.5M | $181.4M | $150.8M | $120.0M | $112.2M |
| Stock-based compensation | $104.3M | $91.7M | $80.2M | $71.1M | $65.3M | $63.9M | $57.6M | $52.1M | $48.4M | $45.9M |
| Change in working capital | −$74.2M | $16.7M | $44.8M | −$462.1M | −$708.1M | $1.4M | −$97.9M | −$177.1M | $9.1M | −$89.9M |
| Other non-cash items | $8.3M | $6.7M | $39.1M | −$10.8M | $20.7M | $5.4M | $39.6M | $28.6M | $12.0M | $3.6M |
| Cash from operating activities | $1.81B | $1.75B | $1.40B | $693.3M | $351.1M | $736.7M | $802.3M | $459.1M | $505.0M | $414.1M |
| Investing activities | ||||||||||
| Capital expenditures | −$156.3M | −$89.9M | −$114.9M | −$134.0M | −$156.0M | −$116.8M | −$105.9M | −$77.3M | −$71.5M | −$71.5M |
| Investments (net) | −$17.3M | −$200.0M | −$269.8M | −$1.16B | −$13.9M | −$158.5M | −$46.0M | −$47.0M | −$29.5M | −$3.1M |
| Acquisitions & other investing | −$371.6M | $89.9M | $114.9M | $134.0M | −$60.0M | $116.8M | −$27.9M | −$951.4M | −$902,000 | −$7.3M |
| Cash from investing activities | −$545.2M | −$200.0M | −$269.8M | −$1.16B | −$229.9M | −$158.5M | −$179.9M | −$1.08B | −$101.8M | −$81.9M |
| Financing activities | ||||||||||
| Dividends paid | −$349.7M | −$310.9M | −$282.3M | −$258.3M | −$245.3M | −$226.7M | −$225.1M | −$211.7M | −$199.5M | −$186.3M |
| Share repurchases & issuance (net) | −$700.0M | −$300.0M | −$150.0M | $1.07B | $47.4M | $90.0M | $1.19B | −$22.8M | −$53.8M | −$102.1M |
| Net borrowing (repayment) | −$10.0M | −$40.0M | −$730.0M | $665.0M | $122.0M | −$522.0M | −$94.0M | $807.5M | −$796.2M | −$95.0M |
| Shares issued | $74.5M | $74.4M | $53.1M | $49.1M | $47.4M | $37.8M | $48.2M | $36.7M | $0 | $0 |
| Other financing | −$21.8M | −$29.8M | −$10.1M | −$1.10B | −$99.8M | −$143.7M | −$1.24B | −$29.0M | $22.8M | $120.5M |
| Cash from financing activities | −$1.01B | −$606.3M | −$1.12B | $422.9M | −$128.4M | −$764.6M | −$317.3M | $580.6M | −$1.03B | −$262.9M |
| Summary | ||||||||||
| Net change in cash | $259.8M | $971.1M | $10.5M | −$45.8M | −$21.6M | −$167.9M | $316.0M | −$41.6M | −$633.2M | $90.5M |
| Cash at end of period | $1.47B | $1.21B | $238.4M | $227.9M | $273.7M | $295.3M | $463.2M | $147.1M | $188.7M | $821.9M |
| Free cash flow | $1.65B | $1.66B | $1.29B | $559.3M | $195.1M | $619.9M | $696.3M | $381.7M | $433.6M | $342.6M |
| Free cash flow margin | 29.2% | 32.3% | 27.5% | 13.2% | 5.5% | 19.4% | 23.5% | 14.6% | 18.5% | 16.6% |
| Capex / revenue | 2.8% | 1.7% | 2.5% | 3.2% | 4.4% | 3.7% | 3.6% | 3.0% | 3.1% | 3.5% |
| Operating cash flow / net income | 1.19 | 1.25 | 1.37 | 0.77 | 0.45 | 1.55 | 1.29 | 1.13 | 1.60 | 1.21 |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating activities | ||||||||||||
| Net income | $1.52B | $398.7M | $392.6M | $348.5M | $379.7M | $365.0M | $344.6M | $311.4M | $292.2M | $300.5M | $208.8M | $219.4M |
| Depreciation & amortization | $55.1M | $69.0M | $62.3M | $57.7M | $74.3M | $51.9M | $55.9M | $53.7M | $54.8M | $54.6M | $53.4M | $53.4M |
| Stock-based compensation | $104.3M | $26.8M | $28.9M | $21.2M | $24.8M | $24.1M | $22.6M | $20.2M | $21.4M | $20.4M | $19.8M | $18.5M |
| Change in working capital | −$74.2M | $117.0M | −$142.3M | $25.3M | $9.7M | $132.3M | $59.4M | −$59.4M | $57.1M | $40.8M | −$9.2M | −$9.6M |
| Other non-cash items | $197.3M | −$57.5M | −$1.8M | $4.7M | $50.4M | $5.3M | −$173.9M | −$283,000 | $14.6M | −$14.4M | $16,000 | $4.5M |
| Cash from operating activities | $1.81B | $554.1M | $339.7M | $457.3M | $538.8M | $578.7M | $308.6M | $325.5M | $440.1M | $402.0M | $272.8M | $286.3M |
| Investing activities | ||||||||||||
| Capital expenditures | −$156.3M | −$33.7M | −$34.6M | −$43.0M | −$30.6M | −$23.8M | −$18.9M | −$19.6M | −$26.3M | −$23.1M | −$23.4M | −$40.9M |
| Investments (net) | −$1.1M | $6.4M | −$16.4M | −$52.6M | −$133.7M | −$31.8M | −$36.7M | $2.1M | −$46.5M | −$33.2M | −$41.1M | −$149.0M |
| Acquisitions & other investing | −$387.8M | −$30.8M | $0 | $43.0M | $30.6M | $23.8M | $18.9M | $19.6M | $26.3M | $23.1M | $23.4M | $40.9M |
| Cash from investing activities | −$545.2M | −$58.0M | −$50.9M | −$52.6M | −$133.7M | −$31.8M | −$36.7M | $2.1M | −$46.5M | −$33.2M | −$41.1M | −$149.0M |
| Financing activities | ||||||||||||
| Dividends paid | −$349.7M | −$87.2M | −$87.6M | −$87.8M | −$77.6M | −$77.7M | −$77.7M | −$77.9M | −$70.6M | −$70.5M | −$70.7M | −$70.6M |
| Share repurchases & issuance (net) | −$700.0M | −$175.0M | −$175.0M | −$150.0M | −$100.0M | −$75.0M | −$75.0M | −$50.0M | −$50.0M | −$50.0M | −$50.0M | $105.0M |
| Net borrowing (repayment) | −$5.0M | $0 | −$5.0M | $0 | −$5.0M | $0 | −$5.0M | −$30.0M | — | — | — | −$80.0M |
| Shares issued | $29.3M | $7.4M | $29.6M | $8.2M | $30.2M | $9.0M | $26.9M | $8.4M | $27.7M | $4.9M | $19.5M | $983,000 |
| Other financing | $18.4M | −$418,000 | −$20.3M | −$719,000 | −$11.4M | −$364,000 | −$16.7M | −$1.2M | −$300.4M | −$220.3M | −$137.8M | −$106.5M |
| Cash from financing activities | −$1.01B | −$255.2M | −$258.3M | −$230.3M | −$163.9M | −$144.1M | −$147.5M | −$150.8M | −$393.3M | −$335.9M | −$239.0M | −$151.1M |
| Summary | ||||||||||||
| Net change in cash | $259.8M | $243.4M | $33.2M | $174.4M | $276.7M | $410.8M | $95.6M | $188.0M | $451,000 | $27.7M | $1.1M | −$18.8M |
| Cash at end of period | $1.47B | $1.66B | $1.42B | $1.38B | $1.21B | $932.7M | $521.9M | $426.4M | $238.4M | $237.9M | $210.2M | $209.1M |
| Free cash flow | $1.65B | $520.5M | $305.2M | $414.4M | $508.2M | $554.9M | $289.7M | $305.9M | $413.8M | $378.9M | $249.5M | $245.4M |
| Free cash flow margin | 112.7% | 36.4% | 21.4% | 31.0% | 37.7% | 43.0% | 22.6% | 25.0% | 33.8% | 31.7% | 21.5% | 22.3% |
| Capex / revenue | 10.7% | 2.4% | 2.4% | 3.2% | 2.3% | 1.8% | 1.5% | 1.6% | 2.2% | 1.9% | 2.0% | 3.7% |
| Operating cash flow / net income | 1.19 | 1.39 | 0.87 | 1.31 | 1.42 | 1.59 | 0.90 | 1.05 | 1.51 | 1.34 | 1.31 | 1.30 |
Negative numbers are cash paid out. Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported; data from EODHD.
RMD cash generation
In fiscal 2026 (ended June 30, 2026), ResMed generated $1.8 billion of cash from operations (up 3.1%) and spent $156.3 million on capital expenditures, leaving free cash flow of $1.6 billion, 29.2% of revenue. It returned $1.0 billion to shareholders through dividends ($349.7 million) and net share buybacks ($700.0 million). Cash and equivalents rose by $259.8 million over the year.
Related: RMD income statement, RMD balance sheet, RMD dividend history. See the RMD stock overview for the latest quote and news.
RMD cash flow FAQ
What is ResMed's free cash flow?
ResMed's free cash flow was $1.6 billion in fiscal 2026: $1.8 billion of operating cash flow minus $156.3 million of capital expenditures It was $1.7 billion a year earlier..
How much cash does ResMed generate from operations?
ResMed generated $1.8 billion of cash from operating activities in fiscal 2026, 1.19 times its net income of $1.5 billion.
How much does ResMed spend on capital expenditures?
ResMed spent $156.3 million on capital expenditures in fiscal 2026, 2.8% of revenue, compared with $89.9 million the year before.
How much stock does ResMed buy back?
ResMed spent $700.0 million on net share repurchases in fiscal 2026.
How much does ResMed pay in dividends?
ResMed paid $349.7 million in dividends in fiscal 2026, 21.2% of free cash flow.